Monosodium alendronate

Alendronate A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

Molecular Formula: C₄H₁₂NNaO₇P₂

InChI: InChI=1/C4H13NO7P2.Na/c5-3-1-2-4(6,13(7,8)9)14(10,11)12;/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12);/q;+1/p-1/fC4H12NO7P2.Na/h7-8,10H;/q-1;m

InChIKey: InChIKey=CAKRAHQRJGUPIG-AJQZKILTCQ
SMILES: C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+]

Names:
    ALENDRONATE SODIUM
    Fosamax
    MK 217
    Monosodium alendronate
    Phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt
    sodium [4-amino-1-hydroxy-1-(hydroxy-oxido-phosphoryl)butyl]phosphonic acid
    (4-Amino-1-hydroxybutylidene)bisphosphonic acid monosodium salt
    129318-43-0

Registries:
    PubChem CID 62958
    PubChem ID 205143